fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » TATA India PHARMA Healthcare Fund

TATA India PHARMA & Healthcare Fund - G

NAV  ₹30.6404 ↓ -0.13  (-0.43 %) as on 21 Jul 25

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 12.5% since its launch.  Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 21 Jul 25₹30.6404 ↓ -0.13  (-0.43 %)
Net Assets (AUM) as on 30 Jun 2025 ₹1,282 Cr.
Launch Date28 Dec 2015
CategoryEquity - Sectoral
RatingNot Rated
TypeOpen Ended Fund
RiskHigh
AMCTata Asset Management Limited
Alpha Ratio2.42
Expense Ratio0.0 %
Sharpe Ratio0.473
Information Ratio0.73
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹150
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Jul 25

DurationReturns
1 Month 4.2%
3 Month 6.3%
6 Month 2.4%
1 Year 11.9%
3 Year 23.8%
5 Year 21.4%
10 Year
15 Year
Since launch 12.5%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2024 40.4%
2023 36.6%
2022 -8%
2021 19.1%
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%

Growth of 10k Over Years

DateValue
30 Jun 20₹10,000
30 Jun 21₹15,403
30 Jun 22₹13,787
30 Jun 23₹16,370
30 Jun 24₹23,471
30 Jun 25₹27,032

Asset Allocation

Asset ClassValue
Cash9.16%
Equity90.84%

Sector Allocation

SectorValue
Health Care88.47%
Basic Materials2.37%

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
Drug Manufacturers - Specialty & Generic12%₹143 Cr854,300
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
Medical Care Facilities6%₹77 Cr111,255
↑ 10,000
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA
Drug Manufacturers - Specialty & Generic6%₹72 Cr490,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
Drug Manufacturers - Specialty & Generic6%₹71 Cr615,100
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic6%₹69 Cr104,965
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS
Medical Care Facilities5%₹60 Cr855,100
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN
Drug Manufacturers - Specialty & Generic5%₹59 Cr303,240
Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM
Medical Care Facilities4%₹54 Cr956,991
Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA
Drug Manufacturers - Specialty & Generic3%₹40 Cr274,871
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY
Drug Manufacturers - Specialty & Generic3%₹39 Cr311,555
1 - 10 of 41
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Meeta Shetty9 Mar 214.23 Yr.
Rajat Srivastava16 Sep 240.71 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Services Ltd
AddressNew No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX91-44-28283610
Emailenq_L@camsonline.com

Administrator Companies

CompanyAddress
Tata Mutual Fund1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

CompanyAddress
Deloitte Haskins & Sells LLP12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment
₹30.6404
↓ -0.13
2.35 %11.86 %23.81 %21.44 %
TATA India Pharma & Healthcare Fund
Normal Dividend, Payout
₹30.6404
↓ -0.13
2.35 %11.86 %23.81 %21.44 %
TATA India Pharma & Healthcare Fund
Growth
₹30.6404
↓ -0.13
2.35 %11.86 %23.81 %21.44 %
Data as on 21 Jul 25

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.